Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Precision Proteomics Leader Alamar Biosciences Lists on NASDAQ

Contributed by: PR Newswire

Tags

QimingVenturePartners

More Like This

PR Newswire associated0

Alamar Biosciences joins forces with SciLifeLab to advance understanding of human disease

GlobeNewswire associated0

Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research

PR Newswire associated0

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

PR Newswire associated0

Alamar Biosciences Achieves ISO 13485 Certification, Demonstrating its Commitment to Quality and Safety

PR Newswire associated0

Alamar Biosciences Establishes European Headquarters and Distribution Center in Milan, Italy

PR Newswire associated0

Alamar Biosciences Launches Certified Service Provider Program to Expand Access to NULISA technology for Academic and Biopharmaceutical Researchers

PR Newswire associated0

Alamar Biosciences Expands Executive Leadership to Power Next Phase of Growth

PR Newswire associated0

Alamar Biosciences, Alzheimer's Disease Data Initiative, and Gates Ventures Unite in Global Partnership to Advance Translational Research in Alzheimer's Disease.

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us